The 2026 APFED HOPE Grant funds innovative research into eosinophil-associated diseases to spark new scientific directions and support future breakthroughs.
Funder: American Partnership for Eosinophilic Disorders
Due Dates (Anticipated): April 2027 (Application deadline, projected)
Funding Amounts: $100,000 total ($50,000/year for 2 years) plus up to $1,000 travel grant
Summary: Supports innovative research projects on eosinophil-associated diseases (excluding nasal polyposis), aiming to stimulate new directions and future external funding.
Key Information: Grant funds cannot be used for PI salary or indirect costs; only direct research expenses and technical staff supported.
This opportunity, offered by the American Partnership for Eosinophilic Disorders (APFED), supports investigators launching novel research projects focused on eosinophil-associated diseases, with the exception of nasal polyposis. The goal is to encourage the development of new ideas that align with APFED’s priorities—improving diagnostics or therapeutics for these diseases—and are likely to lead to future external funding. Funding is intended for direct research expenses, including supplies, services, and technical staff, but not for the applicant’s own salary or institutional indirect costs. The grant also provides a travel stipend for presenting research findings at a professional meeting.